Reuters Health: COVID vaccine proved safe, well tolerated in patients with rheumatic diseases
UC expert recommends further study differentiates between treatment, disease types
A new European study recently published in the Annals of Rheumatic Diseases shows that currently available COVID-19 vaccines rarely cause flares in patients with rheumatic and musculoskeletal disease. Flares were reported in less than 5% of all cases within the study.
While encouraging, Wenhai Shao, PhD, associate professor in the Division of Immunology, Allergy and Rheumatology in the University of Cincinnati's Department of Internal Medicine, told Reuters Health that further studies should differentiate whether patients are taking immunosuppressants or other types of drugs, compare to healthy individuals and note the severity of the rheumatic or musculoskeletal diseases when the vaccination was given for more specific results.
"A bioinformatics approach could be used to analyze the data in these different ways," Shao said.
Read the Reuters Health article.
Featured photo at top of vaccination courtesy of Shutterstock.com
Related Stories
WVXU: Health benefits and risks to recreational marijuana
December 1, 2023
The University of Cincinnati's LaTrice Montgomery joined WVXU's Cincinnati Edition to discuss the potential health benefits and harms associated with expanded cannabis access after Ohio voters approved legalizing recreational marijuana in the November election.
Local 12: New research could help treat cocaine use disorder by...
December 1, 2023
New research out of the University of Cincinnati takes a different approach to cocaine addiction. Local 12 produced a story on the study, interviewing lead researcher Andrew Norman, PhD, of the Department of Pharmacology and Systems Physiology at the UC College of Medicine.
Clean Earth Rovers cofounders named to Forbes 30 Under 30 list
November 30, 2023
A pair of graduates of the University of Cincinnati’s Venture Lab program were recognized as being among the top entrepreneurs in North America as part of the 2024 Forbes 30 Under 30 list. Clean Earth Rovers cofounders Michael Arens and David Constantine were named to the 13th annual Forbes 30 Under 30 list in the energy category.